ERK1/2 inhibition overcomes resistance to venetoclax in AML by altering mitochondrial metabolism

被引：0
|
作者：
Sharma, Priyanka
Ostermann, Lauren
Piya, Sujan
Baran, Natalia
Tyagi, Anudishi
Hindley, Christopher
Dao, Kim-Hien
Sims, Martin
Battula, V. Lokesh
Andreeff, Michael
Borthakur, Gautam
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3860
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3860
引用
收藏
页数：2
相关论文
共 50 条
  • [1] ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Altering Drp1-Dependent Mitochondrial Fission and Metabolism
    Sharma, Priyanka
    Piya, Sujan
    Baran, Natalia
    Zal, Anna
    Hindley, Christopher J.
    Dao, Kim-Hien
    Sims, Martin
    Zal, Tomasz
    Ruvolo, Vivian
    Andreeff, Michael
    Borthakur, Gautam
    BLOOD, 2022, 140 : 8789 - 8790
  • [2] ERK1/2 Inhibition Overcomes Resistance to Venetoclax in AML By Inhibiting Drp1 Dependent Mitochondrial Fission
    Sharma, Priyanka
    Ostermann, Lauren B.
    Piya, Sujan
    Ke, Baozhen
    Baran, Natalia
    Tyagi, Anudishi
    Muftuoglu, Muharrem
    Basyal, Mahesh
    Zhang, Qi
    Munck, Joanne
    Dao, Kim-Hien
    Sims, Martin
    Carter, Bing Z.
    Battula, Venkata Lokesh
    Andreeff, Michael
    Borthakur, Gautam
    BLOOD, 2023, 142
  • [3] ERK1/2 Inhibition Overcomes Resistance in Acute Myeloid Leukemia (AML) and Alters Mitochondrial Dynamics
    Sharma, Priyanka
    Piya, Sujan
    Ma, Huaxian
    Baran, Natalia
    Zal, Malgorzata Anna
    Hindley, Christopher J.
    Dao, Kim-Hien
    Sims, Martin
    Zal, Tomasz
    Ruvolo, Vivian
    Andreeff, Michael
    Borthakur, Gautam
    BLOOD, 2021, 138
  • [4] Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response
    Sharon, David
    Cathelin, Severine
    Mirali, Sara
    Di Trani, Justin M.
    Yanofsky, David J.
    Keon, Kristine A.
    Rubinstein, John L.
    Schimmer, Aaron D.
    Ketela, Troy
    Chan, Steven M.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (516)
  • [5] Inhibition of ERK1/2 Reverses Venetoclax-Induced Autophagy to Overcome Resistance in Acute Myeloid Leukemia
    Sharma, Priyanka
    Piya, Sujan
    Baran, Natalia
    Muftuoglu, Muharrem
    Basyal, Mahesh
    Ruvolo, Vivian
    Hindley, Christopher J.
    Dao, Kim-Hien
    Sims, Martin
    Andreeff, Michael
    Borthakur, Gautam
    BLOOD, 2022, 140 : 3093 - 3094
  • [6] Inhibition of the ERK1/2 pathway by RanBPM
    Atabakhsh, Elnaz
    Schild-Poulter, Caroline
    CANCER RESEARCH, 2012, 72
  • [7] Targeting Mitochondrial Translation Overcomes Venetoclax Resistance in Acute Myeloid Leukemia (AML) through Activation of the Integrated Stress Response
    Sharon, David
    Cathelin, Severine
    Subedi, Amit
    Williams, Ryan
    Benicio, Mariana
    Ketela, Troy
    Chan, Steven M.
    BLOOD, 2017, 130
  • [8] ERK1/2 Inhibition Alleviates Diabetic Cardiomyopathy by Suppressing Fatty Acid Metabolism
    Mclean, Erin
    De Roo, Caroline
    Maag, Annabel
    Coble, Megan
    Cano, Jefferson
    Liu, Ruijie
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2025, 30 (01):
  • [9] ERK Inhibition Overcomes Acquired Resistance to MEK Inhibitors
    Hatzivassiliou, Georgia
    Liu, Bonnie
    O'Brien, Carol
    Spoerke, Jill M.
    Hoeflich, Klaus P.
    Haverty, Peter M.
    Soriano, Robert
    Forrest, William F.
    Heldens, Sherry
    Chen, Huifen
    Toy, Karen
    Ha, Connie
    Zhou, Wei
    Song, Kyung
    Friedman, Lori S.
    Amler, Lukas C.
    Hampton, Garret M.
    Moffat, John
    Belvin, Marcia
    Lackner, Mark R.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (05) : 1143 - 1154
  • [10] Selective inhibition of MCL1 overcomes venetoclax resistance in a murine model of myelodysplastic syndromes
    Fischer, Melissa A.
    Song, Yuanbin
    Arrate, Maria P.
    Gbyli, Rana
    Villaume, Matthew T.
    Smith, Brianna N.
    Childress, Merrida A.
    Stricker, Thomas P.
    Halene, Stephanie
    Savona, Michael R.
    HAEMATOLOGICA, 2023, 108 (02) : 522 - 531
12345